Upon activation, RA CD4+ T cells derived from PBMCs expressed significantly higher inflammatory cytokines such as IL-17, TNF-α and IFN-γ as compared to healthy controls (Figures 2A–D). This evidence concerns the gene CD4 and rheumatoid arthritis.